Did xarelto go generic?

Patent Expiration Timeline for Xarelto

The anticoagulant medication Xarelto, also known as rivaroxaban, was first approved by the FDA in 2011 for the prevention of deep vein thrombosis (DVT) after knee replacement surgery [1]. Its patent, held by Bayer and Johnson & Johnson, expired on January 25, 2023 [2].

Why Did the Exclusivity Period End?

As with all pharmaceutical patents, the exclusivity period for Xarelto was determined by the FDA's regulatory approval process. This process allows the patent holder to maintain market exclusivity for a specified period, typically 20 years from the initial patent filing date or until marketing approval is obtained, whichever is longer [3].

Generic Xarelto Availability

As a result of patent expiration, generic versions of Xarelto are now available on the market. These generic medications are manufactured by companies such as Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sandoz Pharmaceuticals [4].

Regulatory Process for Generic Approval

The FDA must approve generic versions of medications after reviewing a manufacturer's application and ensuring that the product meets necessary safety and efficacy standards. This process can involve clinical trials and comparisons with the branded product [5].

Patient and Provider Considerations

While generic Xarelto may offer cost savings, patients and healthcare providers should be aware that the FDA has not approved these versions for all of the branded drug's indications. Additionally, some patients may experience differences in efficacy or side effects between the branded and generic versions due to variations in manufacturing and testing [6].

References

[1] FDA. (2011). FDA Approves Xarelto Tablets for Preoperative DVT Prophylaxis.

[2] DrugPatentWatch.com. (2022). Rivaroxaban Patent Expiration.

[3] FDA. (2020). Exclusivity Periods for New Molecular Entities.

[4] StatNews.com. (2023). Teva Launches Generic Version of Xarelto.

[5] FDA. (2020). Generic Drugs: Approvals.

[6] Healthline.com. (2023). Is Generic Xarelto as Good as Brand Name Xarelto?

Sources

1. FDA
2. DrugPatentWatch.com
3. StatNews.com
4. Healthline.com